Diagnos
Tracked across 1 events · 7 articles · First seen Apr 08, 2026 · Last active Apr 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
Diagnos is providing updates on the regulatory pathway for its flagship product CARA, indicating progress in commercialization efforts in key markets like Saudi Arabia, Canada, and the United States. This progress is expected to positively impact the company's future revenue and market position.
Apr 08, 2026 · 7 articles
90
Diagnos Provided regulatory update for CARADiagnos CARA Regulatory...
70
Diagnos Engaged in review process Saudi Arabia===Saudi Food and Drug AuthorityDiagnos CARA Regulatory...
70
Diagnos Targeting submission Canada===Health CanadaDiagnos CARA Regulatory...
60
Diagnos Completed annual registration United States===Food and Drug AdministrationDiagnos CARA Regulatory...
50
Diagnos Aims to provide more information to healthcare cliniciansDiagnos CARA Regulatory...
Diagnos===CARA (medical device)
developer of
↔
Diagnos
Diagnos is the developer of the AI-powered medical device CARA.
Saudi Arabia===Saudi Food and Drug Authority
regulator of
↔
Diagnos
The Saudi Arabia===Saudi Food and Drug Authority regulates medical device commer
NEWSDESK
Track Diagnos live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard